Pharmacological studies with an aqueous extract obtained from leaves of Capraria biflora showed potent cytotoxic,
analgesic, antimicrobial and anti-inflammatory activities. It has been demonstrated that
biflorin possesses an in vitro cytotoxic activity against
tumor cells. The in vivo antitumor activity of
biflorin was evaluated on two mouse models,
sarcoma 180 and Ehrlich
carcinoma.
Biflorin was active against both
tumors with a very similar profile. In addition,
biflorin was also able to increase the response elicited by
5-FU in mice inoculated with both
tumors. The results showed a decrease in Ki67 staining in
tumor cells from treated-animals when compared with non-treated groups, which suggests an inhibition of
tumor proliferation rate. Histopathological analysis from kidneys and liver showed that
biflorin possessed weak and reversible toxic effects. It was also demonstrated that
biflorin acts as an
immunoadjuvant agent, rising the production of
ovalbumin-specific
antibodies and inducing a discreet increase of the white pulp and nest of megakaryocytic in spleen of treated mice, which can be related to its antitumor properties.